Page last updated: 2024-08-24

zileuton and 2019 Novel Coronavirus Disease

zileuton has been researched along with 2019 Novel Coronavirus Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Andrade, ACDSP; Barbosa, CLN; Costa, VV; Cruz, JS; da Silva, BLV; da Silva, GSF; de Souza-Costa, LP; Ferreira, R; Machado, FS; Oliveira, FBR; Oliveira, NFM; Pereira, RDD; Porto, SLT; Queiroz-Junior, CM; Rabelo, RAN; Santos, FRDS; Teixeira, MM; Umezu, HL1
Citron, F; Deem, AK; Genovese, G; Perelli, L; Viale, A1

Other Studies

2 other study(ies) available for zileuton and 2019 Novel Coronavirus Disease

ArticleYear
A 5-Lipoxygenase Inhibitor, Zileuton, Modulates Host Immune Responses and Improves Lung Function in a Model of Severe Acute Respiratory Syndrome (SARS) Induced by
    Viruses, 2023, 10-04, Volume: 15, Issue:10

    Topics: Animals; COVID-19; Disease Models, Animal; Humans; Immunity, Innate; Lipoxygenase Inhibitors; Lung; Mice; Mice, Transgenic; SARS-CoV-2; Weight Loss

2023
Leukotrienes, a potential target for Covid-19.
    Prostaglandins, leukotrienes, and essential fatty acids, 2020, Volume: 161

    Topics: Acetates; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Betacoronavirus; Coronavirus Infections; COVID-19; Cyclopropanes; Cytokine Release Syndrome; Humans; Hydroxyurea; Immunologic Factors; Indoles; Leukotrienes; Pandemics; Phenylcarbamates; Pneumonia, Viral; Quinolines; SARS-CoV-2; Severity of Illness Index; Sulfides; Sulfonamides; Tosyl Compounds

2020